New industry: CE qualification for chemiluminescence detection products
According to the announcement of the new industry, the company's PIVKA - Ⅱ (CLIA) abnormal prothrombin assay kit (chemiluminescence immunoassay) has completed all the procedures of EU access, can paste CE mark into the EU market, and increase the reagent menu of advantageous project category "tumor markers", which will further enhance the comprehensive competitiveness of the company's products.
This text is a result of machine translation.
Briefing Jan 11, 2021 07:49 PM
· Healthcare
Hot landscape: net profit will increase by about 216% in 2020
In depth
Healthcare
Bid for Molecular Tech in China's Early-Stage Cancer Detection Market
China, with a population of 1.4 billion, has one of the largest gene pools in the world. How does its DNA tech-based cancer detection industry look? Listed on Nasdaq in 2020, Genetron Holdings Limited (Genetron Health) is taking a leading role.
Sep 09, 2020 03:08 PM
Briefing Jan 11, 2021 10:49 AM
· Healthcare
With a daily detection flux of 1 million, Huada Zhizao automatic nucleic acid extraction and purification instrument helps Hebei epidemic prevention and control
Research
Consumer Staples, Technology, HealthcareWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Dec 09, 2020 08:55 AM
Aug 09, 2020 12:23 AM
Briefing Jan 11, 2021 10:09 AM
· Healthcare
Xinqing medical, a domestic artificial heart and lung device enterprise, won the B round financing of over 100 million yuan from Aurora Borealis venture capital
Briefing Jan 08, 2021 11:30 AM
· Healthcare
Xinyi biological completed 150 million round B financing, and Lilly Asia Fund led investment in Huachuang capital, hillhood venture capital and other follow-up investment
Briefing Jan 08, 2021 09:36 AM
· Healthcare
Focus on high-throughput single-cell omics platform products, search for a reason to complete more than 100 million yuan round a financing
Briefing Jan 07, 2021 04:13 PM
· Healthcare
Qiuzhen medical and tianguangshi have reached strategic cooperation to develop diagnostic kits and tumor drugs
Healthcare
WIM2020: Insights on the Post-pandemic Outlook for the Healthcare Industry
The curtain came down on Dec 10 on the 'Healthtech Industry and COVID-19 Pandemic' Chapter at WIM 2020. Healthtech entrepreneurs and investors gathered to share insights on the outlook for the healthcare industry, covering topics like vaccination, AI healthcare, intelligent hardware, medical appliances and IVD.
Jan 07, 2021 02:10 PM
Automotive, Real Estate, Healthcare
WIM2020: Uniting the World through Technology and Innovation
On December 9-12, EqualOcean held the World Innovators Meet (WIM) 2020. This year, the event's main topic was 'Technology and Innovation Connect the World.' WIM2020 gathered innovators from Asia, Africa, Europe and North America to share their knowledge and key achievements, promoting the concept of 'Tech for Equal.'
Dec 17, 2020 07:53 PM
Briefing Dec 31, 2020 10:20 AM
· Healthcare
Sinopharm new coronavirus vaccine approved
Briefing Dec 30, 2020 05:28 PM
· Healthcare
Another protein component special medical food was approved, and the total number of approved products increased to 57
Briefing Dec 28, 2020 03:13 PM
· Healthcare
Phase I project of Guangzhou Pharmaceutical production base of nuocheng Jianhua was completed
Briefing Dec 28, 2020 02:44 PM
· Healthcare
BGI and Hanwei intelligent medical jointly launched mobile "two cancer" intelligent screening
Briefing Dec 26, 2020 07:11 PM
· Healthcare
Shunyi completed three rounds of full coverage nucleic acid testing for farmers' markets and cold chain logistics, all of which were negative.
Briefing Dec 24, 2020 08:16 PM
· Healthcare
Haizheng Pharmaceutical Co., Ltd.: restructuring matters, suspension of trading on the same day of the meeting on December 25
Briefing Dec 24, 2020 06:01 PM
· Healthcare
Tebo Bio: recognized as a high tech enterprise again
See more
Read next
Consumer Staples · Analysis
Pinduoduo Poised to Win Next Battle in China's E-commerce War
yesterday 10:22 AM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.